课题基金 / 基金详情

Screening for inhibitors of Cholesteryl Ester Transfer Protein

Screening for inhibitors of Cholesteryl Ester Transfer Protein
胆固醇酯转移蛋白抑制剂的筛选
批准号:
09480147
负责人:
TOMODA Hiroshi
金额:
$2.88万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1999

项目摘要

项目成果

TOMODA Hiroshi的其他基金

相似基金

相关文献

中文摘要
翻译
Cholesteryl ester transfer protein (CETP) promotes exchange and transfer of neutral lipids such as cholesteryl ester (CE) and TG between plasma lipoproteins。证据已经累积了CETP在动脉粥样硬化中的重要性。因此,对CETP的抑制被提议作为一个新颖的目标来实现抗动脉粥样硬化药物。有趣的是,CETP介导的脂质转移机制仍然不清楚。在事实上,小分子调制CETP活动已被广泛搜寻以促进治疗和生物化学用途,超过2000个微文化兄弟的样本被提交给CETP抑制剂的筛选程序。最后,我们发现了来自真菌神经系的Erabulenol和来自活性细胞系的Ferroverdin,作为一种新颖的CETP抑制剂。我们也观察到已知的真菌代谢物, sclerotiorin原始分离为黄色颜料和L 681512化合物分离为弹性酶抑制剂和抑制CETP活动。从模型反应中, sclerotiorin可以与一种初级胺反应,如N末端半胱氨酸和/或赖氨酸在CETP分子中形成一种结合键。Among CETP inhibitors of natural origin ferroverdin B show very potent CETP inhibition with a nanomolar ICイイD250イエD2 value。体外效应被用来显示转基因老鼠用于Sclerotiorin和L 681512。
英文摘要
Cholesteryl ester transfer protein (CETP) promotes exchange and transfer of neutral lipids such as cholesteryl ester (CE) and TG between plasma lipoproteins. Evidence has been accumulating of the importance of CETP in atherosclerosis. Therefore, inhibition of CETP is proposed as a novel target for anti-atherosclerotic drugs. Interestingly, the mechanism of CETP-mediated lipid transfer is still unclear. In fact, small molecules modulating the CETP activity have been searched for extensively for therapeutic and biochemical purposes.Over twenty thousand samples of microbial culture broths were subjected to our screening program for CETP inhibitors. Finally, we discovered erabulenols from a fungal strain, and ferroverdins from an actinomycete strain, as novel CETP inhibitors. We also observed that known fungal metabolites, sclerotiorin originally isolated as a yellow pigment and L681512 compounds isolated as elastase inhibitors, inhibit CETP activity.From the model reaction, sclerotiorin can react with a primary amine such as N-terminal cysteine and/or lysines in CETP molecule to form a covalent bond. Among CETP inhibitors of natural origin ferroverdin B show very potent CETP inhibition with a nanomolar ICィイD250ィエD2 value. Ex vivo efficacy was shown using transgenic mice for sclerotiorin and L681512.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
N. Tabata, H. Tomoda, and S. Omura: "Erabulenols A and B, inhibitors cholesteryl ester transfer protein, produced by Penicillium sp. FO-5637. II.Structure elucidation of erabulenols A and B"J. Antibiot. 51. 624-628 (1998)
N. Tabata、H. Tomoda 和 S. Omura:“Erabulenols A 和 B,胆固醇酯转移蛋白抑制剂,由青霉属 sp. FO-5637 产生。II.erabulenols A 和 B 的结构阐明”J。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
N.Tabata, H.Tomoda, and S.Omura: "Erabulenoles A and B, inhibitors of cholesteryl ester transfer protein, produced by Penicillium sp. FO-5637. II. Structure elucidation of erabulenols A and B"J. Anitibiot.. 51. 624-628 (1998)
N.Tabata、H.Tomoda 和 S.Omura:“Erabulenoles A 和 B,胆固醇酯转移蛋白抑制剂,由青霉属 sp. FO-5637 产生。II.erabulenoles A 和 B 的结构阐明”J。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
N.Tabata,H.Tomoda,Y.Yamaguchi,R.Masuma: "Inhibition of cholesteryl ester transfer protein by fungal metabolites, L681.512"J.Antibiot.. 52. 1042-1045 (1999)
N.Tabata,H.Tomoda,Y.Yamaguchi,R.Masuma:“真菌代谢物对胆固醇酯转移蛋白的抑制,L681.512”J.Antibiot.. 52. 1042-1045 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
N.Tabata, H.Tomoda,S.Omura: "Ferroverdins, Inhibitors of cholesteryl ester transfer protein produced by Streptomyces sp.WK-5344.II.Structure elucidation"J.Antibiot.. 52. 1108-1113 (1999)
N.Tabata、H.Tomoda、S.Omura:“Ferroverdins,链霉菌属 sp.WK-5344 产生的胆固醇酯转移蛋白的抑制剂。II.结构阐明”J.Antibiot.. 52. 1108-1113 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 21 条
    THE CHEMICAL BIOLOGY OF NEW MICROBIAL ANTI-INFECTIVE AGENTS
    • 批准号:
      21310146
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.07万
    • 财政年份:
      2009
    • 负责人:
      TOMODA Hiroshi
    • 依托单位:
    Discovery and development of selectivity-defined inhibitors toward two acyl-CoA : cholesterol acyltransferase isozymes
    • 批准号:
      18390008
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.11万
    • 财政年份:
      2006
    • 负责人:
      TOMODA Hiroshi
    • 依托单位:
    国内基金
    海外基金
    去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
    • 批准号:
      31970691
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      张胜萍
    • 依托单位:
    TM9SF4调控非小细胞肺癌细胞凋亡机制研究
    • 批准号:
      31900527
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2019
    • 负责人:
      孙磊
    • 依托单位:
    丹参酮ⅡA联合miR-29b inhibitor调控TGF-β1 / Smad3协同促进肌腱功能修复的机制研究
    • 批准号:
      81702135
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卢荟
    • 依托单位:
    ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究